IgA dominates the early neutralizing antibody response to SARS-CoV-2

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Science Translational Medicine

Topics

Biology

Immunology

Medicine

Internal Medicine

Infectious Diseases

Show all topics

DOI

10.1126/scitranslmed.abd2223

License

CC-BY

Other Formats

PDF